{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:10:46Z","timestamp":1759569046209,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3903,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.exphem.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T02:01:26Z","timestamp":1311818486000},"page":"977-985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade"],"prefix":"10.1016","volume":"39","author":[{"given":"Larry D.","family":"Bozulic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne T.","family":"Ildstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.06.008_bib1","first-page":"23","article-title":"Pre-existing autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation","volume":"24","author":"Nelson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.exphem.2011.06.008_bib2","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/blood-2004-04-1340","article-title":"Preconditioning of NOD mice with anti-CD8 mAb and co-stimulatory blockade enhances chimerism and tolerance and prevents diabetes while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect","volume":"105","author":"Ildstad","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.06.008_bib3","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.20451","article-title":"Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism","volume":"50","author":"Burt","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.exphem.2011.06.008_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.bbmt.2007.03.001","article-title":"Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect","volume":"13","author":"Van","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2011.06.008_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.156.1.380","article-title":"Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in non-obese diabetic (NOD) mice","volume":"156","author":"Li","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s002680020340","article-title":"Impact of bone marrow transplantation on type I diabetes","volume":"25","author":"Domenick","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.exphem.2011.06.008_bib7","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.158.5.2435","article-title":"Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow","volume":"158","author":"Kaufman","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib8","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1084\/jem.188.12.2267","article-title":"Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response","volume":"188","author":"Ridgway","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2011.06.008_bib9","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4049\/jimmunol.164.5.2444","article-title":"Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation","volume":"164","author":"Dahlen","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib10","doi-asserted-by":"crossref","first-page":"15806","DOI":"10.1073\/pnas.2636971100","article-title":"Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases","volume":"100","author":"Alyanakian","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.06.008_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1681\/ASN.V641143","article-title":"T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction","volume":"6","author":"Sayegh","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.exphem.2011.06.008_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007890-199504270-00013","article-title":"Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient","volume":"59","author":"Burlingham","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2011.06.008_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4049\/jimmunol.172.3.1691","article-title":"Critical role of OX40 in CD28 and CD154-independent rejection","volume":"172","author":"Demirci","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-6143.2004.00384.x","article-title":"Multiple combination therapies involving blockade of ICOS\/B7RP-1 costimulation facilitate long-term islet\u00a0allograft survival","volume":"4","author":"Nanji","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.exphem.2011.06.008_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.172.3.1463","article-title":"Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.TP.0000069602.30162.A1","article-title":"Blockade of the CD40\/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy","volume":"76","author":"Pan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2011.06.008_bib17","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-10-3869","article-title":"Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)","volume":"105","author":"Taylor","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.06.008_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diabetes.53.2.376","article-title":"Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity","volume":"53","author":"Nikolic","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/nm931","article-title":"Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade","volume":"9","author":"Monk","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2011.06.008_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/89731","article-title":"Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection","volume":"2","author":"Ozkaynak","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/diabetes.55.01.06.db04-1154","article-title":"Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet\u00a0allografts and prevents spontaneous autoimmune diabetes in the NOD mouse","volume":"55","author":"Nanji","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI11220","article-title":"CD28-independent induction of experimental autoimmune encephalomyelitis","volume":"107","author":"Chitnis","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2011.06.008_bib24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.1840170629","article-title":"Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance","volume":"17","author":"Starzl","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.exphem.2011.06.008_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","article-title":"Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice","volume":"51","author":"Rabinovitch","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00007890-199609150-00019","article-title":"Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10","volume":"62","author":"Faust","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2011.06.008_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2337\/diabetes.50.2.270","article-title":"Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation","volume":"50","author":"Molano","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/diabetes.52.2.321","article-title":"NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction","volume":"52","author":"Pearson","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2337\/diabetes.48.5.967","article-title":"NOD mice have a generalized defect in their response to transplantation tolerance induction","volume":"48","author":"Markees","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.exphem.2011.06.008_bib30","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.177.6.3695","article-title":"Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells","volume":"177","author":"Ly","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.06.008_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2567.2008.02958.x","article-title":"Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3(+) regulatory T cells","volume":"127","author":"Hubner","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2011.06.008_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1196\/annals.1361.048","article-title":"Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice","volume":"1051","author":"Piccirillo","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2011.06.008_bib33","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1182\/blood-2010-06-291187","article-title":"CD8a+ plasmacytoid precursor DC induce antigen-specific regulatory T cells that enhance HSC engraftment in\u00a0vivo","volume":"117","author":"Huang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.06.008_bib34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1600-6143.2010.03018.x","article-title":"Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning","volume":"10","author":"Pilat","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:29Z","timestamp":1759566569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0301472X11002888"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.06.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}